Skip to content

Clinical trials

Phase 3 Muscular Dystrophy, Duchenne trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Phase: Phase 3 Country / region: Netherlands Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20131
20161
20171
20181
20203
20212
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated5
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Italfarmaco2
Kyntra Bio2
NS Pharma, Inc.2
Santhera Pharmaceuticals2
Avidity Biosciences, Inc.1
Eli Lilly and Company1
Sarepta Therapeutics, Inc.1
University Hospital, Basel, Switzerland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne14
Muscular Dystrophies4
Genetic Diseases, Inborn2
Muscular Diseases2
Muscular Disorders, Atrophic2
Musculoskeletal Diseases2
Nervous System Diseases2
Neuromuscular Diseases2
Genetic Diseases, X-Linked1
Infant, Newborn, Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.